Skip to main content

Table 3 Advantages of NLCs compared to SLNs limitations regarding ocular drug delivery

From: Nanotechnology-based strategies overcoming the challenges of retinoblastoma: a comprehensive overview and future perspectives

Advantages of NLCs

Disadvantages of SLNs

Superior encapsulation efficiency

Excellent ocular permeability

Proper pharmacokinetic characteristics

Extended and controlled drug release

Maintaining adequate drugs’ concentrations within the aqueous humor, vitreous humor, and retina

-Increasing pre-corneal drug retention

Increasing drugs’ corneal permeation

Increasing ocular bioavailability and distribution

Positively-charged NLCs have shown to promote a prolonged ocular residence time, circumventing ocular toxicity owing to their close contact with negatively charged mucus membrane

Superior biocompatibility and stability

Initial burst release of SLNs

Low drug loading efficiency

SLNs for ocular drug delivery have not recently assessed through extensive clinical trials, and most investigations have only undergone in-vitro evaluations

Retinal cell toxicity of SLNs has not been thoroughly studied till current date